[Ala107]-MBP (104-118)

[Ala107]-MBP (104-118) is a synthetic peptide derived from the myelin basic protein (MBP), specifically encompassing residues 104 to 118 with an alanine substitution at position 107. This peptide fragment is widely recognized for its relevance in neurobiological and immunological research, particularly in studies investigating the structure and function of MBP within myelin sheaths of the central nervous system. The alanine modification at residue 107 allows researchers to explore the impact of specific amino acid substitutions on protein conformation, antigenicity, and molecular interactions, providing a refined tool for dissecting the biochemical roles of MBP in both physiological and pathological contexts.

Epitope Mapping: The modified peptide is frequently utilized in the mapping of immunodominant epitopes within MBP, particularly in the context of autoimmune demyelinating diseases such as multiple sclerosis. By substituting alanine at position 107, investigators can delineate critical residues involved in T-cell recognition and antibody binding, thus clarifying the molecular determinants of immune reactivity to MBP. This approach aids in the identification of sequence-specific immune responses and supports the development of targeted immunological assays.

Protein-Structure Function Analysis: Incorporation of [Ala107]-MBP (104-118) in structure-function studies enables detailed examination of how single-residue alterations influence the folding, stability, and intermolecular interactions of MBP-derived peptides. Researchers employ this analog to compare biophysical properties such as secondary structure formation, aggregation propensity, and binding affinity to other myelin-associated proteins or lipid membranes. Such analyses are essential for understanding the fundamental mechanisms underlying myelin assembly and maintenance.

Autoimmunity Research: The peptide serves as a valuable probe in experimental models of autoimmunity, where it is used to investigate the role of MBP fragments in eliciting or modulating T-cell responses. The alanine substitution provides a means to assess the specificity and cross-reactivity of autoreactive lymphocytes, contributing to the characterization of pathogenic versus tolerogenic immune mechanisms. These studies are instrumental in elucidating the molecular basis of central nervous system autoimmunity and in identifying potential targets for immunomodulatory intervention.

Peptide-Based Assay Development: Researchers employ the alanine-substituted MBP fragment as a standard or control in the design and optimization of peptide-based immunoassays, including ELISA and T-cell proliferation assays. Its defined sequence and known immunogenic properties facilitate the calibration of assay sensitivity and specificity, thereby improving the reliability of experimental measurements involving MBP-reactive antibodies or T cells. This application supports robust data generation in both basic and translational research settings.

Peptide Synthesis Validation: In the context of synthetic peptide production, [Ala107]-MBP (104-118) is often used as a model substrate to validate solid-phase peptide synthesis protocols and analytical methods. The presence of a single-site substitution enables precise evaluation of synthesis fidelity, sequence verification, and purification strategies. Such validation studies are critical for ensuring the consistency and reproducibility of peptide-based reagents used in downstream biochemical and immunological experiments.

1. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications

2. Implications of ligand-receptor binding kinetics on GLP-1R signalling

3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

4. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

5. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance